1. Home
  2. VWAV vs PRQR Comparison

VWAV vs PRQR Comparison

Compare VWAV & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VWAV

VisionWave Holdings Inc.

HOLD

Current Price

$4.82

Market Cap

139.7M

Sector

Technology

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.91

Market Cap

166.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VWAV
PRQR
Founded
2024
2012
Country
United States
Netherlands
Employees
12
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.7M
166.5M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
VWAV
PRQR
Price
$4.82
$1.91
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.25
AVG Volume (30 Days)
560.9K
546.9K
Earning Date
05-18-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.06
$1.33
52 Week High
$15.80
$3.10

Technical Indicators

Market Signals
Indicator
VWAV
PRQR
Relative Strength Index (RSI) 42.34 69.50
Support Level $4.72 $1.93
Resistance Level $6.64 $2.03
Average True Range (ATR) 0.53 0.12
MACD -0.02 0.05
Stochastic Oscillator 2.74 93.55

Price Performance

Historical Comparison
VWAV
PRQR

About VWAV VisionWave Holdings Inc.

VisionWave Holdings Inc is a technology company focused on the development and commercialization of artificial intelligence (AI) and autonomous solutions across air, ground and sea environments. Through its subsidiary, the Company designs and deploys technologies including radars, radio frequency (RF) sensing, unmanned aerial and ground systems, remote weapon stations and active protection systems for defense, military, homeland security and industrial applications. Its proprietary AI engine supports autonomous decision-making and product lines at various stages of development and commercialization. Revenue is generated through product sales, technology licensing, strategic alliances and joint ventures, with products including C-UAS, multi-purpose autonomous UAS and Vision-AI technology.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: